Jeff Brown Omnia DNA Technology (Near Future Report by Brownstone Research)

Right off the bat, people are likely to wonder, wow, 133,000% growth potential in just two years, how’s that possible? Our editorial team was wondering the same. So, we decided to watch a recent interview where host Chris Hurt discussed matters with the tech investor who came forward with the investment idea, Jeff Brown. Established figures like Bill Gates refer to this discovery as “one of the most powerful technologies of the 21st century.” Not to forget one of many influential persons, Elon Musk, who insists that “It has amazing potential.”

What is OMNIA?

What got us hooked to this technology, which Jeff refers to as “Omnia,” is its ability to disrupt the agriculture, healthcare, food retail, energy, and manufacturing sectors, and this is just the beginning! How can anyone overlook its ability to save close to $7,000 on gas over 30 years? Especially now, with all the inflation, and the Ukraine-Russian war, almost everything has seen a massive price hike.

After some exchange of words, the expert revealed what he refers to as Omnia. These are stocks that operate within the DNA technology sector. He maintained that “Omnia” means “everything” and DNA technology has the power to change EVERYTHING we do as humans,” even detecting and putting an end to common genetic diseases such as Alzheimer’s, hepatitis, blindness, and cancer among others. Seeing how Jeff has his eyes set out on DNA technology, wouldn’t it be great to know which stocks he is most hopeful of? If the answer is yes, such knowledge can be acquired by becoming a The Near Future Report member.

What is The Near Future Report?

The Near Future Report is an investment advisory developed to identify the “trends of today,” primarily those reaching the point of mass adoption. By the looks of it, it seems like Jeff is predominantly interested in large-capitalization growth stocks. Some examples include 5G, artificial intelligence, and cloud computing. Taking everything into account, let’s proceed to the membership incentives.

What Are Members Entitled to via the Near Future Report?

For individuals who decide to become a member of The Near Future Report today, access to the following special reports will be immediately granted:

Special Report #1. One California Company at The Forefront of the 133,000% DNA Megatrend

Inside the first report, Jeff gives away the details of one California company at the forefront of DNA technology via a DNA sequencer machine. He will provide a complete analysis, company name, and ticker symbol. So, what is it about this company that’s got him convinced? They’ve possessed one of the most dominant and powerful patent libraries and a virtual monopoly over DNA technology. Consequently, this company will indeed be riding the adoption of DNA technology over the next 24 months, says the expert. He is pretty confident because Craig Venter co-founds it, and billionaire Peter Diamandis has a stake in it.

Special Report #2. DNA Fortunes: Your Chance to Grab A Large Gain from The Hemophilia Cure

The following company on his watchlist is one to dominate the $11 trillion healthcare industry. More specifically, the company intends to use DNA technology to cure hemophilia, which has a 5-fold higher risk of death. Thanks to the technology at hand, a cure has finally been developed, and it supposedly helped 120 people suffering from the condition in clinical trials. Presently, this company is the only one to have found a cure, and they are awaiting FDA approval for it.

Special Report #3. DNA Technology: The Cure to The Little-Known Cancer

The last opportunity worth investing in is a company using DNA technology to help cure lymphoma cancer. Former director at the Yale Center for DNA Analysis, Dr. John Overton, and former professor at the DNA technology center at Baylor College, Dr. Jeffrey Reid, are part of this company. The latter is an asset considering their success in amassing one of the world’s largest databases of DNA sequences, permitting them to introduce a cure.

Besides these special reports, members will automatically have access to:

• A whole year of The Near Future Report with a new recommendation every month along with a comprehensive report
• 24/7 access to Jeff’s model portfolio
• Instant entry to Jeff’s digital vault of past issues and special reports ever released via The Near Future Report
• Weekly updates and urgent alerts on any recommendation made
• Professional U.S.-based customer support
• 60-day money-back guarantee

How Much Does a Membership to the Near Future Report Cost?

Usually, a membership to The Near Future Report would cost $199. However, Jeff has discounted the price to $49 for the first year and $129 after as a limited-time offer. As mentioned earlier, each subscription has also been protected by a 60-day money-back guarantee. If members decide The Near Future Report isn’t suitable for their respective goals, customer service can be contacted for a full purchase price refund. More on the steps to getting refunded can be gathered by visiting here:

• Phone: 1 (888) 493 3156
• Email: memberservices@brownstoneresearch.com.
• Address: 55 NE 5th Avenue, Delray Beach, FL 33484

Meet Jeff Brown

Jeff Brown is the founder of Brownstone Research, a research group that delivers unique investment advisory newsletters. Before bringing this service to life, Jeff spent a good portion of his career serving high-technology executive member roles, is an active angel investor, and is a member of an elite network. He also prides himself as an avid researcher who tests the specifics of innovations on the front line and the field before recommending them to the masses. He has insider scoops that the public rarely has access to. Did we also mention that his knowledge spans several industries, DNA technology, semiconductors, video technology, or security?

OMNIA Final Verdict

From Jeff’s interview with Chris Hurt, individuals should have gathered that the expert has his eyes on companies making full use of DNA technology. Our editorial team sees this as an exciting yet valuable space that might support those looking to diversify their respective portfolios. The main reason is that DNA technology serves multiple purposes. For people wondering why to consider Jeff an apt editor, his expertise revolves around technology of all kinds. Moreover, he gets insider scoops on innovation well before most people do. By everything discussed thus far, we believe $49 is a great way to see the market from his stance. To learn more about DNA technology and stocks Jeff views as “Omnia,” click here>>>.

RELATED:Jeff Brown The Last American Dollar Review (Near Future Report)

Affiliate Disclosure:

The links contained in this product review may result in a small commission if you opt to purchase the product recommended at no additional cost to you. This goes towards supporting our research and editorial team. Please know we only recommend high-quality products.

Disclaimer:

Please understand that any advice or guidelines revealed here are not even remotely substitutes for sound medical or financial advice from a licensed healthcare provider or certified financial advisor. Make sure to consult with a professional physician or financial consultant before making any purchasing decision if you use medications or have concerns following the review details shared above. Individual results may vary and are not guaranteed as the statements regarding these products have not been evaluated by the Food and Drug Administration or Health Canada. The efficacy of these products has not been confirmed by FDA, or Health Canada approved research. These products are not intended to diagnose, treat, cure or prevent any disease and do not provide any kind of get-rich money scheme. Reviewer is not responsible for pricing inaccuracies. Check product sales page for final prices.

Comments are closed.